Muscular Disease

Neurology·MeSH: Neuromuscular Diseases

5 drugs in development·3 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
lonvoguran ziclumeran	Intellia Therapeutics, Inc. (NTLA)
nexiguran ziclumeran	Intellia Therapeutics, Inc. (NTLA)

Phase 1(3)

Drug	Company
anito-cel	Arcellx, Inc. (ACLX)
KER-065	Keros Therapeutics, Inc. (KROS)
Standard Lymphodepletion regimen	Arcellx, Inc. (ACLX)

BioSniper tracks 5 drugs in development for Muscular Disease across 3 companies.

There are 1 clinical trial targeting Muscular Disease tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.